IQVIA Holdings (NYSE: IQV) plans brokered sale of 558 common shares

Rhea-AI Filing Summary

IQVIA Holdings Inc. has a planned sale of 558 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE, targeted for 07/29/2026. The shares are valued at $136,827.18, tied to earlier restricted stock and performance share awards granted by the issuer on multiple dates from 2022 through 2026.

Key Figures

Shares planned for sale: 558 shares Indicated aggregate value: $136827.18 Referenced price figure: 164600000 +5 more

8 metrics

Shares planned for sale 558 shares Common stock to be sold through Morgan Stanley Smith Barney LLC on 07/29/2026

Indicated aggregate value $136827.18 Value associated with the 558 common shares planned for sale

Referenced price figure 164600000 Price-related figure listed with the 558-share planned sale entry

Planned sale date 07/29/2026 Target date for sale of common stock on the NYSE

Restricted stock grant on 02/11/2022 1 Restricted stock from issuer dated 02/11/2022 linked to the position

Restricted stock grant on 02/09/2023 91 Restricted stock from issuer dated 02/09/2023 linked to the position

Restricted stock grant on 07/28/2025 66 Restricted stock from issuer dated 07/28/2025 linked to the position

Performance shares grant on 02/08/2026 140 Performance Shares from issuer dated 02/08/2026 linked to the position

Key Terms

Restricted Stock, Performance Shares, Securities To Be Sold, Securities Sold During The Past 3 Months

4 terms

Restricted Stock financial

"Common | 02/11/2022 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Performance Shares financial

"Common | 02/08/2026 | Performance Shares | Issuer"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/29/2026 - 04:10 PM Accepted by SEC EDGAR 07/29/2026 - 04:10 PM Learn about SEC filing dates

FAQ

What stock transaction is disclosed for IQV in this Form 144-style notice?

The notice covers a planned sale of 558 shares of IQVIA common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE, with the transaction targeted for 07/29/2026 and an indicated value of $136,827.18.

What is the indicated value of the IQV shares to be sold?

The filing lists the 558 IQVIA shares with an aggregate value of $136,827.18, alongside a referenced price figure of 164600000. These figures frame the scale of the planned stock sale for the reporting holder.

Through which broker will the IQV shares be sold?

The common shares of IQVIA Holdings Inc. (IQV) are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004, with the shares listed on the NYSE.

What types of awards underlie the IQV shares in this planned sale?

The planned sale relates to IQVIA common shares originally acquired as Restricted Stock and Performance Shares. The awards were granted by the issuer across several dates between 02/11/2022 and 02/08/2026, later forming part of the shares to be sold.

Which prior grant dates are associated with the IQV restricted stock?

Underlying restricted stock grants associated with the IQVIA shares were dated 02/11/2022, 02/09/2023, 02/11/2023, 07/28/2023, 02/09/2024, 02/10/2024, and 07/28/2025. These issuer grants later contributed to the position planned for sale.

Is any recent three-month sale activity reported for IQV in this notice?

The section labeled “Securities Sold During The Past 3 Months” appears without specific transaction details. The main disclosure instead focuses on the proposed sale of 558 IQVIA common shares scheduled for 07/29/2026 on the NYSE.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	558	136827.18	164600000	07/29/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2022	Restricted Stock	Issuer			1	02/11/2022	Not Applicable
Common	02/09/2023	Restricted Stock	Issuer			91	02/09/2023	Not Applicable
Common	02/11/2023	Restricted Stock	Issuer			82	02/11/2023	Not Applicable
Common	07/28/2023	Restricted Stock	Issuer			65	07/28/2023	Not Applicable
Common	02/09/2024	Restricted Stock	Issuer			91	02/09/2024	Not Applicable
Common	02/10/2024	Restricted Stock	Issuer			22	02/10/2024	Not Applicable
Common	07/28/2025	Restricted Stock	Issuer			66	07/28/2025	Not Applicable
Common	02/08/2026	Performance Shares	Issuer			140	02/08/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)